BLUEBIRD STRATEGIES

Lobbying for MYOTONIC · Patient advocacy organization.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · posted Apr 6, 2026

Lobbying activity 2

Medical/Disease Research/Clinical Labs

Funding for myotonic dystrophy research as part of the FY27 Congressionally Directed Medical Research Program & Peer Review Medical Research Program.

Budget/Appropriations

Myotonic dystrophy biomedical research funding

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.